Profile and Organisation
Bayer is a global enterprise with core competencies in the fields of health care, agriculture and high-tech materials. As an inventor company, it sets trends in research-intensive areas. Bayer’s products and services are designed to benefit people and improve the quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power.
Bayer is committed to the principles of sustainable development and acts as a socially and ethically responsible corporate citizen. In fiscal 2012, Bayer employed 110,500 people and had sales of €39.8 billion. Capital expenditures amounted to €2 billion, R&D expenses to €3 billion.
Organisation
Bayer AG defines common values, goals and strategies for the entire Group. The three subgroups and three service companies operate independently, led by the management holding company. The Corporate Center supports the Group Management Board in its task of strategic leadership.
|
Click here to download organisation chart with management structure and fields of activity.
Business operations are the responsibility of the subgroups:
- Bayer HealthCare is among the world’s foremost innovators in the field of pharmaceutical and medical products.
- Bayer CropScience, with its highly effective products, pioneering innovations and keen customer focus, holds global leadership positions in crop protection and non-agricultural pest control.
- Bayer MaterialScience is a renowned supplier of high-performance materials such as polycarbonates and polyurethanes, and innovative system solutions for a wide range of everyday uses.
Central service functions are combined into three service companies:
- Bayer Business Services is the Bayer Group’s international competence center for it-based services.
- Bayer Technology Services is the global technological backbone for the Bayer Group and a major innovation driver.
- Currenta offers services for the chemical industry including utility supply, waste management, infrastructure, safety, security, analytics and vocational training.
Corporate Governance
Dual governance system with the following governance bodies:
| Board of Management: | four members, Chairman: Dr. Marijn Dekkers |
| Supervisory Board: | 20 members, Chairman: Werner Wenning |
Products
The Bayer Group markets some 5,000 products. Best-sellers include:
- in the health care field: Yasmin®/YAZ®/Yasminelle®, Betaferon®/Betaseron®, Kogenate®, Adalat®, Avelox®/Avalox®
- in the nutrition field: Confidor®/ Gaucho®/Admire®/Merit®, Flint®/Stratego®/Sphere®
- in the field of high-tech materials: Makrolon®, Bayblend®, BaySystems® Footwear, Desmodur®/Desmophen®
Locations
Bayer is represented around the world by about 280 companies*. Global headquarters are in Leverkusen, Germany.
*fully consolidated subsidiaries (as of Dec. 31, 2012)
Workforce
|
Bayer Stock
- included in nearly all the major share indices
- traded on all German stock exchanges
- dividend per share: EUR 1.65 (2012)
Bayer Group Key Data
| Bayer Group |
2011 |
2012 |
Change |
| Sales | 36,528 | 39,760 |
8.8 |
| EBIT1 | 4,149 | 3,960 |
-4.6 |
| EBIT before special items2 | 5,025 | 5,671 |
12.9 |
| EBITDA3 | 6,918 | 6,920 |
0.0 |
| EBITDA before special items2 |
4,452 |
8,284 |
8.8 |
| Income before income taxes | 3,363 | 3,248 |
-3.4 |
| Net income | 2,470 | 2,446 |
-1.0 |
| Earnings per share (€)5 | 2.99 | 2.96 |
-1.0 |
| Gross cash flow7 | 5,172 | 4,599 |
-11.1 |
| Net cash flow8 | 5,060 | 4,532 |
-10.4 |
| Capital expenditures as per segment table |
1,666 | 2,012 |
20.8 |
|
Research and development expenses |
2,932 | 3,013 |
2.8 |
|
Dividend per Bayer AG share (€) |
1.65 | 1.90 |
15.2 |
1-8 for definition see footnotes to Bayer Group Key Data table
Share of Sales by Segment 2012 (2011 in parentheses)
|

Overview
Overview
Profile and Organisation




